Zhuang Li

机构：Qilu Hospital of Shandong University · ORCID：0000-0001-6855-2803

发表论文 67 篇 · 总被引 683 次 · h-index 14

代表论文

• Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer (2025 · International Journal of Cancer · 被引 134)
• Incorporation of protein induced by vitamin K absence or antagonist-II into transplant criteria expands beneficiaries of liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study in China (2023 · International Journal of Surgery · 被引 21)
• Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 20)
• The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study (2024 · International Journal of Surgery · 被引 14)
• Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in China (2024 · International Journal of Surgery · 被引 13)
• The impact of lymphadenectomy on the survival outcomes of ovarian clear cell carcinoma: A retrospective study of the SEER database and Chinese registry (2024 · European Journal of Surgical Oncology · 被引 7)